StockData
BioAge Labs, Inc. logo

BioAge Labs, Inc. (BIOA) stock

BIOANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/30
$4.77−0.33 (-6.47%)

Close on Nov 18, 2026Market cap $218.93MP/E –Yield –

BioAge Labs total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

BioAge Labs's total debt was $0 at Jun 30, 2026. For fiscal 2025 it was $2.65M, down 68.9% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.65M-68.9%
FY2024Dec 31, 2024$8.50M-40.1%
FY2023Dec 31, 2023$14.20M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$0-100.0%
Q1 FY2026Mar 31, 2026$1.16M-83.6%
Q4 FY2025Dec 31, 2025$2.65M-68.9%
Q3 FY2025Sep 30, 2025$4.13M-58.5%
Q2 FY2025Jun 30, 2025$5.60M-60.6%
Q1 FY2025Mar 31, 2025$7.06M–
Q4 FY2024Dec 31, 2024$8.50M–
Q3 FY2024Sep 30, 2024$9.94M–
Q4 FY2023Dec 31, 2023$14.20M–

More BioAge Labs figures

See a number that looks wrong?